Bolt Biotherapeutics, Inc. (BOLT) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on June 4, 2025, by Bolt Biotherapeutics, Inc., a Delaware corporation. The report details a corporate action approved by the Board of Directors and stockholders on May 27, 2025, regarding a reverse stock split.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a capital structure adjustment rather than financial performance results.
Material Changes
- Reverse Stock Split: A one-for-twenty (1:20) reverse stock split was approved to become effective at 5:00 p.m. Eastern Time on June 6, 2025.
- Share Conversion: Every 20 shares of issued and outstanding common stock will be automatically converted into one share.
- Equity Adjustments: The split affects shares available under equity incentive plans and employee stock purchase plans. Outstanding stock options, restricted stock units, and warrants will have their share counts reduced with a corresponding increase in exercise prices.
- Fractional Shares: No fractional shares will be issued; eligible stockholders will receive cash payments in lieu thereof.
- Trading Details: Common stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market on June 9, 2025, under the ticker symbol "BOLT". The new CUSIP number is 097702203.
- Par Value: The par value per share remains unchanged at $0.00001.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the mechanics of the reverse stock split. The primary contingency noted is the cash payment for fractional shares.
Key Facts for Investor Verification
- Verify the effective date of the reverse stock split: June 6, 2025, at 5:00 p.m. ET.
- Confirm the new CUSIP number (097702203) for post-split trading.
- Check the adjusted exercise prices and share counts for any held stock options or warrants.
- Monitor the start of split-adjusted trading on June 9, 2025.
- Review the cash payment procedure for fractional shares if applicable to your holdings.